Protease-activated receptors (PARs) are a family of G-protein-coupled receptors. Of the four members so far identified PAR-1, PAR-3 and PAR-4 are thrombin receptors. PAR-1 has been shown to be involved in mediating platelet aggregation, cell proliferation, inflammatory responses and neurodegeneration. Early attempts to develop PAR-1 antagonists failed because of problems of poor efficacy, possibly due to the tethered ligand intramolecular binding following enzymatic receptor cleavage. PAR-1 antagonists, so far developed, can be chemically classified into two major groups: i) peptide/peptidomimetic antagonists; ii) non-peptide based antagonists. Two PAR-1 antagonists, SCH-530348 from Schering-Plough and E-5555 from Eisai Company, are in clinical trials for the prevention of arterial thrombosis.

Thrombin receptors and their antagonists: an update on the patent literature / Cirino, Giuseppe; Severino, Beatrice. - In: EXPERT OPINION ON THERAPEUTIC PATENTS. - ISSN 1354-3776. - STAMPA. - 20:7(2010), pp. 1-10. [10.1517/13543776.2010.487864]

Thrombin receptors and their antagonists: an update on the patent literature

CIRINO, GIUSEPPE;SEVERINO, BEATRICE
2010

Abstract

Protease-activated receptors (PARs) are a family of G-protein-coupled receptors. Of the four members so far identified PAR-1, PAR-3 and PAR-4 are thrombin receptors. PAR-1 has been shown to be involved in mediating platelet aggregation, cell proliferation, inflammatory responses and neurodegeneration. Early attempts to develop PAR-1 antagonists failed because of problems of poor efficacy, possibly due to the tethered ligand intramolecular binding following enzymatic receptor cleavage. PAR-1 antagonists, so far developed, can be chemically classified into two major groups: i) peptide/peptidomimetic antagonists; ii) non-peptide based antagonists. Two PAR-1 antagonists, SCH-530348 from Schering-Plough and E-5555 from Eisai Company, are in clinical trials for the prevention of arterial thrombosis.
2010
Thrombin receptors and their antagonists: an update on the patent literature / Cirino, Giuseppe; Severino, Beatrice. - In: EXPERT OPINION ON THERAPEUTIC PATENTS. - ISSN 1354-3776. - STAMPA. - 20:7(2010), pp. 1-10. [10.1517/13543776.2010.487864]
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11588/375046
Citazioni
  • ???jsp.display-item.citation.pmc??? 6
  • Scopus 17
  • ???jsp.display-item.citation.isi??? 18
social impact